Denali Therapeutics
DNLI
DNLI
148 hedge funds and large institutions have $2B invested in Denali Therapeutics in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+20
Holders Change %
+15.63%
% of All Funds
3.04%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
32
Increased
54
Reduced
37
Closed
11
Calls
$837K
Puts
$324K
Net Calls
+$513K
Net Calls Change
+$629K
Top Buyers
| 1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$63.4M |
| 2 |
2
BlackRock
New York
|
$151M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$54.3M |
| 4 |
CCM
4
CAAS Capital Management
New York
|
$37.6M |
| 5 |
5
UBS AM
Chicago,
Illinois
|
$11.9M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Group One Trading
Chicago,
Illinois
| – | -$101K | -5,756 | Closed |
|
|
ASN
152
Advisory Services Network
Atlanta,
Georgia
| – | -$92K | -5,246 | Closed |
|
|
HR
153
Howe & Rusling
Rochester,
New York
| – | -$2K | -125 | Closed |
|
|
PHK
154
Point72 Hong Kong
Hong Kong
| – | -$2K | -120 | Closed |
|
|
EI
155
Ellevest Inc
New York
| – | -$1K | -33 | Closed |
|